Semaglutide Oral Tablets 7 mg

Semaglutide Oral Tablets 7 mg
Paub meej:
Khoom npe: Semaglutide Oral Tablet 7mg
  • 2 Qhov taw qhia Hom 2 mob ntshav qab zib mellitus; Kev rog rog
  • 1 Hom Innovative Tshuaj
  • 3Daim ntawv Txhaj tshuaj
  • 6 Hom phiaj Dual GLP / GIP receptor agonist
  • 5 Clinical kev kawm Theem Ⅲ kev sim tshuaj.
  • 4 Kwv yees lub sij hawm tso tawm 2027
Xa kev nug
Ces
Hauj lwm lawm
Kev tsis
Cov ntaub ntawv tshawb fawb

 

[Biovailability nyob rau hauv Beagle Dog: Ib koob tshuaj h2h PK kawm]

 

product-1110-375

AUC ntawm BO-017 mg capsule yog 12 npaug siab dua li Rybelsus 7 mg ntsiav tshuaj.

 

[Cov ntaub ntawv tshawb fawb Primate: Sib piv ntawm promate absorption tom qab ib koob tshuaj]

 

Yam khoom

Specification

Kawm paub

Tus lej

AVG Cmax (ng / ml)

AVG T1/2 (hli)

Bioavailability

Rybelsus

5mg ib

ib txwm

n=24

8.3

7.94

0.4~1%(3)

Rybelsus

7mg ib

ib txwm

n=6

4.37

/

0.4~1%(3)

PEB -01

7mg ib

ib txwm

n=5

62.6

51.6

/

 

(1) Keeb kwm los ntawm Rybelsus EMA NDA cov ntaub ntawv
(2) Cov ntaub ntawv hauv tsev
(3) Keeb kwm los ntawm Rybelsus FDA NDA cov ntaub ntawv

BO-01 tso tawm ~ 8 npaug siab dua Rybelsus thaum hais txog lawv ib koob tshuaj Cmax.

BO-01 tso tawm ~ 7 npaug siab dua Rybelsus thaum hais txog lawv ib koob tshuaj T1/2.

 

 

Kev koom tes hauv qhov project

 

Product License-tawm

● Biosimilar polypeptide molecules
● 2.2/505b (2) kev txhim kho
● Liscense-tawm thaum ntxov / lig kev kho mob

Technique License-out

● Client's polypeptide
● Hom 1 tshuaj thawj
● Tus nqi tseem ceeb

 

Certificate Display

 

product-1561-480

 

Cov duab Exhibition

 

product-1562-559

 

Tuam txhab Profile

 

product-1561-649

 

 

Cim npe nrov: Semaglutide Oral Tablets 7mg, Tuam Tshoj Semaglutide Oral Tablets 7mg manufacturers, lwm tus neeg

Xa kev nug